• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human FERM and PDZ domain-containing protein 4 (FRMPD4), Truncated

ACP18460

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP18460 Target NameFRMPD4
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Protein LengthPartialPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ14CM0
Background Information
  • Uniprot Id

    Q14CM0

  • Target Species

    Human

  • Target Name

    FRMPD4

  • Target Full Name

    FERM and PDZ domain-containing protein 4

  • Target Function

    Positive regulator of dendritic spine morphogenesis and density. Required for the maintenance of excitatory synaptic transmission. Binds phosphatidylinositol 4,5-bisphosphate.

  • Target Involvement

    Mental retardation, X-linked 104 (MRX104)

  • Target Subcellular Location

    Cell projection, dendritic spine.

  • Target Synonyms

    FERM and PDZ domain containing 4; FERM and PDZ domain-containing protein 4; Frmpd4; FRPD4_HUMAN; Gm196; KIAA0316; MGC142260; PDZ domain containing 10; PDZ domain containing protein 10; PDZ domain-containing protein 10; PDZD10; PDZK10; Preso; PSD 95 interacting FERM and PDZ domain protein; PSD 95 interacting regulator of spine morpogenesis; PSD-95-interacting regulator of spine morphogenesis; RGD1566031; RP23-217I22.2

Inquire Recombinant Human FERM and PDZ domain-containing protein 4 (FRMPD4), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification